v. 28 – Q4 2023
Market Executive Summary | In Singapore, Health Services Authority (HSA) requirements currently only address primary and secondary product labelling for injectables with a unique (by SKU) product identifier.
Serialization/traceability requirements are not currently under consideration. |
Key Dates |
|